End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 CNY | +1.84% | +8.24% | -1.29% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 53% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- With an expected P/E ratio at 49.9 and 30.24 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.29% | 543M | - | ||
+9.29% | 3.93B | D+ | ||
+5.18% | 1.75B | B+ | ||
+3.44% | 971M | D+ | ||
+9.13% | 968M | - | ||
-2.47% | 698M | - | - | |
+66.88% | 674M | - | - | |
+31.71% | 605M | B- | ||
+15.68% | 497M | - | ||
-25.28% | 397M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300758 Stock
- Ratings Anshan Hifichem Co., Ltd.